Evidence map›Paper›PMID 26100713›Full record

ArticleAntimicrobial agents and chemotherapy2015

Characterization of IncI1 sequence type 71 epidemic plasmid lineage responsible for the recent dissemination of CTX-M-65 extended-spectrum β-lactamase in the Bolivian Chaco region.

Eleonora Riccobono, Vincenzo Di Pilato, Tiziana Di Maggio, Carmen Revollo, Alessandro Bartoloni, Lucia Pallecchi, Gian Maria Rossolini

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Coexistence of blaScientific reports · 2025
    Article
  2. Article
  3. CTX-M-producingOne health (Amsterdam, Netherlands) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. A Multidrug-ResistantMicrobial drug resistance (Larchmont, N.Y.) · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Ceftazidime-Avibactam Resistance Associated with IncreasedAntimicrobial agents and chemotherapy · 2020
    Article
  13. Detection of TnFrontiers in microbiology · 2020
    Article
  14. Article
  15. Article
  16. Multidrug Resistant UropathogenicFrontiers in microbiology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eleonora RiccobonoDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Vincenzo Di PilatoDepartment of Medical Biotechnologies, University of Siena, Siena, Italy Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Tiziana Di MaggioDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Carmen RevolloInstituto Nacional de Laboratorios de Salud "Dr. Nestor Morales Villazón" (INLASA), La Paz, Bolivia.
Alessandro BartoloniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Lucia PallecchiDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Gian Maria RossoliniDepartment of Medical Biotechnologies, University of Siena, Siena, Italy Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy gianmaria.rossolini@unifi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the last decade, a significant diffusion of CTX-M-type extended-spectrum β-lactamases (ESBLs) was observed in commensal Escherichia coli from healthy children in the Bolivian Chaco region, with initial dissemination of CTX-M-2, which was then replaced by CTX-M-15 and CTX-M-65. In this work, we demonstrate that the widespread dissemination of CTX-M-65 observed in this context was related to the polyclonal spreading of an IncI1 sequence type 71 (ST71) epidemic plasmid lineage. The structure of the epidemic plasmid population was characterized by complete sequencing of four representatives and PCR mapping of the remainder (n = 16). Sequence analysis showed identical plasmid backbones (similar to that of the reference IncI1 plasmid, R64) and a multiresistance region (MRR), which underwent local microevolution. The MRR harbored genes responsible for resistance to β-lactams, aminoglycosides, florfenicol, and fosfomycin (with microevolution mainly consisting of deletion events of resistance modules). The bla CTX-M-65 module harbored by the IncI1 ST71 epidemic plasmid was apparently derived from IncN-type plasmids, likely via IS26-mediated mobilization. The plasmid could be transferred by conjugation to several different enterobacterial species (Escherichia coli, Cronobacter sakazakii, Enterobacter cloacae, Klebsiella oxytoca, Klebsiella pneumoniae, and Salmonella enterica) and was stably maintained without selective pressure in these species, with the exception of K. oxytoca and S. enterica. Fitness assays performed in E. coli recipients demonstrated that the presence of the epidemic plasmid was apparently not associated with a significant biological cost.

Indexed as

Anti-Bacterial Agentsbeta-Lactamasesbeta-LactamsEnterobacter cloacaeEnterobacteriaceaeEscherichia coliFosfomycinKlebsiella oxytocaKlebsiella pneumoniaeMicrobial Sensitivity TestsPlasmidsSalmonella entericaAnti-Bacterial Agentsbeta-Lactamasesbeta-LactamsFosfomycin

Identifiers

PMID26100713
PMCPMC4538553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.